AAV cGMP Manufacturing

Reliable CDMO services to facilitate gene therapy

Gene to Virus for AAV and Lentivirus

One-stop solution with incomparable speed and quality!

Lentivirus Packaging Services

Ensuring efficient, effective, safe, and reliable gene delivery

Off-the-shelf mRNA & LNP Gene editing mRNA 30% off

We will assist you from research to clinic!

AAV Capsid Engineering

Proven technology paving your path to effective gene therapy

AAV Packaging in World-leading quality

Fast and Effective in as fast as 12-18 business days

CRO
Discovery and Preclinical Services

One-stop Custom AAV Packaging Services

GMP Manufacturing Services

One-stop CDMO Services for GMP Manufacturing

CDMO-Services

Technology Platforms

π-Omega™ Plasmid DNA High-yield Production Platform
π-Omega Plasmid DNA High-yield Production Platform
π-Alpha™ 293 AAV High-yield Production Platform
π-Alpha 293 AAV High-yield Production Platform
π-Icosa™ AAV Serotype Screening Platform

π-Icosa AAV Serotype Screening Platform

Projects Delivery

Clients

GMP Facility

What Customers Are Saying About Us

Leading technology and global reputation

Decibel, Principal Scientist

“A lot of our programs internally have been having great results with the AAV vectors you all have been packaging. PackGene is rapidly becoming our go-to for AAV vectors! ”

Biogen Scientist

“I  have spreaded  the word of my satisfaction with your AAV vectors to many people in  Biogen’s research labs and I hope we continue to be a regular customer in the future.”

Learn More About Us

PACKGENE-NEWS
EVENTS

ASGCT (Maryland, May 4-11, 2024)

Abstract:Welcome to ASGCT 2024, the American Society of Gene and Cell Therapy's flagship conference. Esteemed researchers, clinicians, and industry leaders converge at this influential event to navigate the forefront of gene and cell therapy. In the vibrant atmosphere...

American Academy of Neurology (Colorado, Apri 13-18, 2024)

Abstract:The American Academy of Neurology Conference 2024 in Denver, a pivotal gathering for the brightest minds in neurology. This esteemed event brings together experts, researchers, clinicians, and innovators from around the globe to explore the forefront of...

Advanced Therapies Congress (London, Mar 19-20, 2024)

Abstract:The Advanced Therapies Congress convenes leaders in cell and gene therapy development across diverse sectors: pharma, biotech, startups, researchers, clinicians, academics, HTAs, payers, and regulators. In 2024, our new Gene Editing Track highlights CRISPR...

MDA (Florida, Mar 3-6, 2024)

Abstract:The Muscular Dystrophy Association (MDA) holds the top spot as the leading voluntary health organization in the United States, catering to individuals grappling with muscular dystrophy, ALS, and associated neuromuscular conditions. For over 70 years, MDA has...

Webinar: Quality Delivery of mRNA – LNP with An Unbeatable Timeline

Abstract:Kudo Biotechnology is a global mRNA CDMO company headquartered in Singapore, providing world-class end-to-end cGMP manufacturing solutions for your mRNA needs. Kudo streamlines the manufacturing process of plasmid DNA, mRNA, lipid nanoparticle (LNP) and...

ESGCT 30th ANNUAL CONGRESS BRUSSELS

Time: 24-27 Oct 2023Address: Maison de la Poste, Bruxelles, Brussels, BelgiumContact: Irene Song (Sr. Director, Global Product) irene.song@packgene.comPoster P149:Generation of novel AAV serotype with enhanced infectivity, specificity, and lower toxicity via π-Icosa...

Meeting on the Mesa

Time: Live partnering meetings October 10-12; Virtual partnering meetings October 17-18Address: Park Hyatt Aviara, Carlsbad, CAContact: Luyan He(Head of Commercial Team) Luyan.He@packgene.com

INDUSTRY NEWS

New FDA Guidance Impacts the CAR-T Industry

In January, the FDA published, “Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products: Guidance for Industry.” To find out how this guidance impacts the CAR-T industry, GEN talked with Klara Sochorová, PhD, senior quality compliance...

Blackstone to Fund up to $750M for Moderna’s Flu Program

Blackstone entered a new collaboration with Moderna, Inc. through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750 million to fund Moderna’s influenza program. Under the agreement, Blackstone...

Epigenetic Editing Explodes on the Heels of Gene Editing Success

Coinciding with the historic approval of Vertex and CRISPR Therapeutics’ Casgevy as the first CRISPR-based therapeutic, epigenetic editing, which targets parts of the genetic code beyond the DNA itself, is having a moment. One company is already in the clinic, and two...

PackGene’s Newsletter

Receive the latest news and insights to your inbox.